Evidence map›Paper›PMID 30586905›Full record

ArticleMaterials (Basel, Switzerland)2018

Tough and Elastic α-Tricalcium Phosphate Cement Composites with Degradable PEG-Based Cross-Linker.

Michaela Rödel, Jörg Teßmar, Jürgen Groll, Uwe Gbureck

Abstract read
In one paragraph

Article in Materials (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Michaela RödelDepartment for Functional Materials in Medicine and Dentistry, University Hospital of Würzburg, Pleicherwall 2, 97070 Würzburg, Germany. michaela.roedel@fmz.uni-wuerzburg.de.
Jörg TeßmarDepartment for Functional Materials in Medicine and Dentistry, University Hospital of Würzburg, Pleicherwall 2, 97070 Würzburg, Germany. joerg.tessmar@fmz.uni-wuerzburg.de.ORCID 0000-0001-7057-5369
Jürgen GrollDepartment for Functional Materials in Medicine and Dentistry, University Hospital of Würzburg, Pleicherwall 2, 97070 Würzburg, Germany. juergen.groll@fmz.uni-wuerzburg.de.ORCID 0000-0003-3167-8466
Uwe GbureckDepartment for Functional Materials in Medicine and Dentistry, University Hospital of Würzburg, Pleicherwall 2, 97070 Würzburg, Germany. uwe.gbureck@fmz.uni-wuerzburg.de.

Funding

Deutsche Forschungsgemeinschaft GB 1/20-1Deutsche Forschungsgemeinschaft GR 3232/3-1Deutsche Forschungsgemeinschaft INST 1522/58-1 FUGG
6 · The paper itself

Abstract

Dual setting cements composed of an in situ forming hydrogel and a reactive mineral phase combine high compressive strength of the cement with sufficient ductility and bending strength of the polymeric network. Previous studies were focused on the modification with non-degradable hydrogels based on 2-hydroxyethyl methacrylate (HEMA). Here, we describe the synthesis of suitable triblock degradable poly(ethylene glycol)-poly(lactide) (PEG-PLLA) cross-linker to improve the resorption capacity of such composites. A study with four different formulations was established. As reference, pure hydroxyapatite (HA) cements and composites with 40 wt% HEMA in the liquid cement phase were produced. Furthermore, HEMA was modified with 10 wt% of PEG-PLLA cross-linker or a test series containing only 25% cross-linker was chosen for composites with a fully degradable polymeric phase. Hence, we developed suitable systems with increased elasticity and 5⁻6 times higher toughness values in comparison to pure inorganic cement matrix. Furthermore, conversion rate from α-tricalcium phosphate (α-TCP) to HA was still about 90% for all composite formulations, whereas crystal size decreased. Based on this material development and advancement for a dual setting system, we managed to overcome the drawback of brittleness for pure calcium phosphate cements.

Indexed as

bending strengthcalcium phosphate cementcomposite materialdual setting systemfree radical polymerizationHEMAhydroxyapatite

Identifiers

PMID30586905
PMCPMC6337656

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.